Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)
- Author
- YAZDANI, U1 ; GERMAN, D. C1 ; LIANG, C.-L1 ; MANZINO, L2 ; SONSALLA, P. K2 ; ZEEVALK, G. D2
[1] Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390-9070, United States
[2] Department of Neurology, UMDNJ-Robert Wood Johnson Medical School, Piscataway, NJ 08854, United States - Source
Experimental neurology (Print). 2006, Vol 200, Num 1, pp 172-183, 12 p ; ref : 1 p.1/4
- Publisher
- Elsevier, Amsterdam
- Publication country
- Netherlands
- Document type
- Article
- Language
- English
- Author keyword
- Chronic model Dopamine Inclusion bodies Neurodegeneration Stereology Substantia nigra
- Keyword (fr)
- Animal Aphagie Chronique Corps Lewy Corps inclusion Dopamine Locus niger Manutention Microscope électronique Mitochondrie Modèle animal Mort cellulaire Mortalité Neurone Neuroprotecteur Parkinson maladie Rat Sporadique Stress Stéréologie Toxine Traitement Trouble fonctionnel Tyrosine 3-monooxygenase Ubiquitine Ventricule cérébral Ventricule gauche Catécholamine Encéphale pathologie Enzyme Extrapyramidal syndrome Maladie dégénérative Mammalia Neurotransmetteur Oxidoreductases Rodentia Système nerveux central pathologie Système nerveux central Système nerveux pathologie Vertebrata
- Keyword (en)
- Animal Aphagia Chronic Lewy body Inclusion body Dopamine Locus niger Handling Electron microscope Mitochondria Animal model Cell death Mortality Neuron Neuroprotective agent Parkinson disease Rat Sporadic Stress Stereology Toxin Treatment Dysfunction Tyrosine 3-monooxygenase Ubiquitin Cerebral ventricle Left ventricle Catecholamine Cerebral disorder Enzyme Extrapyramidal syndrome Degenerative disease Mammalia Neurotransmitter Oxidoreductases Rodentia Central nervous system disease Central nervous system Nervous system diseases Vertebrata
- Keyword (es)
- Animal Afagia Crónico Cuerpo Lewy Cuerpo inclusión Dopamina Locus níger Manutención Microscopio electrónico Mitocondria Modelo animal Muerte celular Mortalidad Neurona Neuroprotector Parkinson enfermedad Rata Esporádico Estrés Estereología Toxina Tratamiento Trastorno funcional Tyrosine 3-monooxygenase Ubiquitina Ventrículo cerebral Ventrículo izquierdo Catecolamina Encéfalo patología Enzima Extrapiramidal síndrome Enfermedad degenerativa Mammalia Neurotransmisor Oxidoreductases Rodentia Sistema nervosio central patología Sistema nervioso central Sistema nervioso patología Vertebrata
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17F Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17G Degenerative and inherited degenerative diseases of the nervous system. Leukodystrophies. Prion diseases
- Discipline
- Neurology
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 18009345
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1016/j.expneurol.2006.02.002 
https://dx.doi.org/10.1016/j.expneurol.2006.02.002
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.expneurol.2006.02.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Experimental neurology (Print)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Exp. neurol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"200\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"172\";s:8:\"\u0000*\u0000epage\";s:3:\"183\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-4886\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"YAZDANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"GERMAN, D. C\";i:1;s:11:\"LIANG, C.-L\";i:2;s:10:\"MANZINO, L\";i:3;s:14:\"SONSALLA, P. K\";i:4;s:13:\"ZEEVALK, G. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EXNEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.expneurol.2006.02.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Experimental neurology (Print)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Exp. neurol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"200\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"172\";s:8:\"\u0000*\u0000epage\";s:3:\"183\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-4886\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"YAZDANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"GERMAN, D. C\";i:1;s:11:\"LIANG, C.-L\";i:2;s:10:\"MANZINO, L\";i:3;s:14:\"SONSALLA, P. K\";i:4;s:13:\"ZEEVALK, G. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EXNEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.expneurol.2006.02.002\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.expneurol.2006.02.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Experimental neurology (Print)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Exp. neurol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"200\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"172\";s:8:\"\u0000*\u0000epage\";s:3:\"183\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-4886\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"YAZDANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"GERMAN, D. C\";i:1;s:11:\"LIANG, C.-L\";i:2;s:10:\"MANZINO, L\";i:3;s:14:\"SONSALLA, P. K\";i:4;s:13:\"ZEEVALK, G. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EXNEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.expneurol.2006.02.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Experimental neurology (Print)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Exp. neurol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"200\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"172\";s:8:\"\u0000*\u0000epage\";s:3:\"183\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-4886\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"YAZDANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"GERMAN, D. C\";i:1;s:11:\"LIANG, C.-L\";i:2;s:10:\"MANZINO, L\";i:3;s:14:\"SONSALLA, P. K\";i:4;s:13:\"ZEEVALK, G. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EXNEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1016\/j.expneurol.2006.02.002\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:9:\"\u0000*\u0000jtitle\";s:30:\"Experimental neurology (Print)\";s:9:\"\u0000*\u0000stitle\";s:20:\"Exp. neurol. (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2006\";s:9:\"\u0000*\u0000volume\";s:3:\"200\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:3:\"172\";s:8:\"\u0000*\u0000epage\";s:3:\"183\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0014-4886\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"YAZDANI\";s:10:\"\u0000*\u0000aufirst\";s:1:\"U\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"GERMAN, D. C\";i:1;s:11:\"LIANG, C.-L\";i:2;s:10:\"MANZINO, L\";i:3;s:14:\"SONSALLA, P. K\";i:4;s:13:\"ZEEVALK, G. D\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"EXNEAC\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:97:\"Rat model of Parkinson's disease : Chronic central delivery of 1-methyl-4-phenylpyridinium (MPP+)\";s:8:\"\u0000*\u0000place\";s:9:\"Amsterdam\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"12\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
